Mechanistically, OA promotes ferroptosis resistance in radioresistant cancer cells in an ACSL3-dependent manner via a reduction in the amount of PUFA-PLs in cell membranes and inhibition of lipid peroxidation and subsequent ferroptosis, leading to cancer radioresistance. The gene discussed is ACSL3; the disease is cancer.